multipl
sclerosi
ms
common
inflammatori
demyelin
degen
diseas
cn
caus
ms
unknown
environment
risk
factor
implic
ms
sever
virus
propos
trigger
ms
late
epsteinbarr
viru
ebv
becom
lead
candid
infecti
aetiolog
fit
number
epidemiolog
observ
addit
immunopatholog
featur
diseas
review
summar
emerg
evid
demonstr
strong
associ
ebv
infect
ms
conundrum
remain
whether
ebv
directli
involv
pathophysiolog
ms
altern
immunopatholog
ms
somehow
affect
regul
ebv
infect
among
environment
risk
factor
propos
ms
infecti
aetiolog
fit
number
epidemiolog
observ
well
immunopatholog
featur
diseas
sever
virus
propos
trigger
ms
epsteinbarr
viru
ebv
becom
lead
candid
recent
year
emerg
evid
demonstr
strong
associ
ebv
infect
sever
autoimmun
diseas
includ
ms
ebv
human
primari
tropism
rest
b
cell
ebv
mainli
transmit
via
saliva
howev
sexual
transmiss
viru
also
report
adult
popul
worldwid
serolog
evid
prior
infect
ebv
ebv
capabl
caus
latent
infect
within
b
cell
although
cell
type
also
infect
cell
epitheli
cell
primari
infect
ebv
follow
bimod
distribut
peak
young
childhood
adolescenceearli
adulthood
earli
childhood
acut
infect
usual
asymptomat
wherea
acut
infect
occur
adolesc
adulthood
subject
may
develop
infecti
mononucleosi
im
follow
infect
ebv
lifelong
latent
viral
presenc
establish
within
b
cell
period
reactiv
result
viru
shed
saliva
time
carrier
may
infect
other
ebv
implic
pathogenesi
sever
diseas
mainli
cancer
difficult
demonstr
caus
role
ebv
autoimmun
diseas
eg
system
lupu
erythematosu
yet
elucid
viral
infect
result
diseas
individu
despit
high
level
ebv
seroposit
within
gener
popul
viru
resid
memori
b
cell
traffic
inflam
tissu
presenc
ebv
could
bystand
phenomenon
lead
misinterpret
evid
associ
ebv
high
number
case
b
cell
malign
burkitt
lymphoma
hodgkin
lymphoma
b
cell
lymphoma
patient
immunosuppress
diseas
cell
malign
nasal
nkt
cell
lymphoma
hemophagocyt
syndrom
cell
lymphoma
epitheli
cell
malign
nasopharyng
carcinoma
lymphoepitheliomalik
carcinoma
sever
featur
support
pathogen
role
ebv
ms
therefor
review
focus
ebv
contributori
factor
ms
discuss
sever
line
evid
strengthen
associ
sinc
earli
remark
similar
epidemiolog
ms
im
note
sever
epidemiolog
featur
ms
associ
higher
socioeconom
statu
occurr
cluster
epidem
chang
preval
latitud
chang
risk
diseas
migrat
could
possibl
explain
role
ebv
pathophysiolog
ms
addit
sever
studi
shown
individu
histori
infecti
mononucleosi
increas
risk
develop
ms
metaanalysi
casecontrol
cohort
studi
im
ms
calcul
combin
rel
risk
ms
im
ci
p
apart
indic
potenti
role
ebv
pathogenesi
ms
find
suggest
time
primari
ebv
infect
import
factor
develop
ms
infect
adolesc
young
adulthood
greater
risk
develop
ms
infect
childhood
shown
high
preval
region
ms
seroconvers
ebv
occur
puberti
larg
proport
popul
danish
studi
patient
im
observ
twofold
increas
risk
ms
im
cohort
confirm
associ
im
ms
also
found
risk
develop
ms
increas
year
im
sever
studi
compar
seropreval
common
ebv
antibodi
ms
patient
healthi
individu
systemat
review
eight
casecontrol
studi
demonstr
nearli
ms
patient
infect
ebv
compar
control
studi
report
odd
ratio
develop
ms
ci
ebvseroposit
individu
second
systemat
review
includ
thirteen
casecontrol
studi
confirm
relat
ebv
seroposit
ms
report
odd
ratio
develop
ms
seroneg
individu
ci
addit
recent
studi
confirm
risk
ms
ebvneg
individu
low
howev
increas
dramat
individu
seroconvers
seroposit
ebv
promin
pediatr
ms
report
ebv
seroposit
rate
nearli
pediatr
ms
patient
compar
agematch
control
recent
studi
show
pediatr
ms
patient
seroposit
ebv
compar
match
control
p
howev
comparison
clinic
manifest
ebvposit
ebvneg
pediatr
ms
patient
show
differ
earlier
younger
age
suggest
ebv
may
fundament
influenc
clinic
manifest
ms
children
serolog
evid
come
longitudin
prospect
studi
blood
sampl
collect
prior
onset
ms
analysi
sera
show
risk
acquir
ms
strongli
associ
increas
level
ebv
antibodi
titer
prior
diseas
onset
strongest
associ
found
igg
antibodi
bind
ebv
latent
nuclear
antigen
addit
recent
longitudin
studi
confirm
risk
ms
ebv
neg
individu
low
howev
increas
dramat
individu
seroconvers
believ
protect
respons
immun
system
ebv
modul
via
secret
neutral
antibodi
nab
nab
block
spread
free
virus
uninfect
cell
one
studi
measur
ebv
nab
titr
ms
patient
healthi
control
signific
differ
two
group
found
studi
signific
correl
igg
nab
earli
antigen
ea
respons
either
group
evid
ebv
serolog
find
might
associ
clinic
radiolog
diseas
activ
ms
ebv
reactiv
appear
link
diseas
activ
earli
ms
found
ms
patient
clinic
relaps
compar
patient
clinic
remiss
evid
peripher
ebv
reactiv
evidenc
increas
igm
iga
respons
ebv
ea
detect
ebv
dna
serum
also
shown
patient
antiebv
earli
antigen
ea
antibodi
radiolog
diseas
activ
term
gadoliniumenhanc
lesion
mri
recent
mri
activ
measur
gdenhanc
lesion
shown
also
correl
igg
capsid
antigen
vca
igg
ratio
addit
igg
titr
antivca
igg
level
correl
volum
chang
year
igg
titr
also
predictor
chang
expand
disabl
statu
scale
edss
studi
followup
period
latter
could
impli
associ
antibodi
diseas
progress
ms
antibodi
ebv
antigen
correl
mri
paramet
antivca
igg
level
posit
correl
lesion
volum
neg
correl
atrophi
paramet
grey
matter
fractiongmfand
brain
parenchym
fractionbpf
increas
antivca
igg
level
associ
greater
decreas
bpf
three
year
denot
associ
ebv
antibodi
loss
brain
volum
studi
igg
neg
associ
gmf
associ
antiebvea
igg
antibodi
mri
paramet
measur
although
demonstr
ebv
viral
load
associ
overal
ms
risk
ebv
viral
load
associ
increas
diseas
activ
shown
patient
clinic
isol
syndrom
ci
immun
respons
igg
ebv
antigen
correl
baselin
number
lesion
number
lesion
meet
barkhof
criteria
baselin
number
lesion
followup
presenc
new
lesion
edss
mean
followup
year
addit
show
increas
igg
respons
predict
convers
ms
base
mcdonald
criteria
correl
found
ebv
igg
respons
number
gadoliniumenhanc
lesion
although
find
base
small
proport
studi
patient
elev
ebvvca
antibodi
also
posit
associ
predispos
factor
ms
healthi
individu
includ
femal
gender
current
smoke
statu
total
number
packyear
smoke
high
ebv
titer
present
confer
risk
ms
consider
increas
one
studi
rel
risk
ms
increas
ninefold
femal
ms
patient
elev
titer
antibodi
impli
interact
two
risk
factor
compar
woman
low
titer
taken
togeth
studi
strongli
indic
ebv
seroposit
possibl
predispos
factor
develop
ms
howev
establish
direct
caus
relat
ms
sinc
observ
result
might
part
gener
immun
dysregul
consequ
ms
addit
exclus
ms
ebv
seroposit
also
associ
autoimmun
diseas
like
system
lupu
erythematosu
might
indic
ebv
play
role
autoimmun
gener
two
studi
investig
whether
strain
differ
ms
patient
healthi
individu
infect
ebv
studi
analys
genotyp
singl
viral
gene
one
studi
show
similar
genotyp
eight
ms
patient
small
commun
denmark
conclud
infect
strain
anoth
studi
howev
found
differ
sequenc
latent
membran
eleven
ms
patient
eleven
control
unlik
strain
ebv
found
ms
patient
futur
studi
focu
chang
sequenc
gene
select
pressur
eg
affect
immun
viral
evas
strategi
may
role
pathogenesi
diseas
associ
ebv
alter
cellular
immun
ebv
ms
patient
may
reflect
either
alter
immun
respons
infect
may
direct
respons
ebv
infect
facilit
aberr
autoimmun
process
individu
ebv
develop
eleg
strategi
enabl
immuneevas
allow
persist
within
host
latent
viral
infect
main
viral
envelop
glycoprotein
bind
complement
receptor
rest
matur
b
cell
initi
ebv
infect
ebv
entri
celltyp
epitheli
cell
depend
combin
nevertheless
presenc
appear
essenti
bind
fusion
ebv
mhc
class
ii
express
cell
ebv
express
two
protein
mimic
activ
receptor
antigenactiv
b
cell
receptor
bcr
respect
b
cell
allow
activ
prolifer
matur
b
cell
persist
ebv
memori
b
cell
independ
cell
dendrit
cell
dc
pivot
elicit
primari
antivir
cell
respons
dc
respons
present
ebv
antigen
necrot
apoptot
b
cell
cell
howev
ebv
develop
mechan
interfer
antigen
present
eg
virion
avoid
entranc
monocyt
ebv
may
interfer
develop
monocyt
dc
latent
phase
ebv
maintain
episom
form
express
reduc
number
gene
downregul
surfac
express
mhc
class
ii
b
cell
ebv
express
abl
mediat
interfer
mhc
class
ii
depend
cell
activ
featur
allow
viru
evad
immun
recognit
henc
prevent
viral
clearanc
latent
ebv
infect
b
cell
associ
express
approxim
gene
cell
prolifer
order
facilit
onward
transmiss
ebv
cell
viru
abl
transient
switch
lytic
phase
approxim
gene
express
memori
ebvspecif
cell
produc
follow
primari
infect
ebv
maintain
immunosurveil
infect
b
cell
unabl
elimin
cell
latent
infect
ebv
cytotox
percentag
ebv
b
cell
peripher
blood
healthi
individu
latent
infect
b
cell
within
peripher
blood
mononuclear
cell
pbmc
yet
known
frequenc
similar
ms
patient
would
give
us
indic
whether
ebvspecif
cell
respons
alter
ms
patient
viral
infect
control
circul
cytotox
cell
viral
protein
undergo
proteosom
degrad
within
infect
cell
result
peptid
upload
onto
mhc
class
molecul
endosom
reticulum
present
cell
surfac
cytotox
cell
cell
respons
measur
frequenc
product
cytotox
assay
sever
studi
investig
cell
respons
ebv
ms
patient
sometim
differ
result
increas
frequenc
cell
reactiv
two
six
differ
ebv
peptid
found
ms
patient
respons
five
one
ebv
restrict
peptid
analyz
group
ms
patient
healthi
control
hc
studi
employ
seven
restrict
ebv
peptid
differ
seen
ms
patient
hc
hla
class
restrict
ebv
peptid
use
increas
cell
respons
detect
peopl
clinic
isol
syndrom
ci
similar
frequenc
found
ms
patient
hc
recent
studi
describ
increas
frequenc
specif
cell
patient
ci
compar
hc
although
frequenc
cell
specif
ebvderiv
immunodomin
tcell
epitop
differ
ci
patient
control
hand
anoth
interest
studi
use
ebv
infect
b
cell
lymphoblastoid
cell
line
lcl
express
latent
lytic
phase
protein
may
repres
physiolog
represent
vivo
situat
report
decreas
cell
immun
ebv
ms
patient
compar
hc
lower
mean
frequenc
pbmc
produc
respons
autolog
lcl
ms
patient
compar
ebvposit
healthi
peopl
measur
elispot
howev
similar
valu
popul
detect
control
antigen
includ
concavalin
tetanu
toxoid
author
hypothes
may
impair
prime
dc
genet
determin
defici
gener
ebv
cell
lead
higher
number
ebv
infect
b
cell
ms
patient
consid
immunogen
protein
develop
strategi
avoid
immun
recognit
long
glycinealanin
repeat
sequenc
hinder
proteosom
degrad
limit
present
cell
repeat
sequenc
delet
immun
recognit
elimin
infect
b
cell
proceed
normal
furthermor
level
express
within
infect
b
cell
enough
maintain
viral
episom
kept
low
level
thu
impair
vigor
immun
respons
helper
cell
recognis
specif
peptid
present
mhc
class
ii
molecul
antigen
present
cell
multipl
role
includ
mainten
cell
function
crosstalk
b
cell
allow
induc
transform
immunoglobulin
produc
cell
studi
ms
patient
healthi
control
show
ms
patient
increas
cell
respons
extens
repertoir
peptid
cover
entir
ctermin
region
great
major
ebv
peptid
specif
cell
memori
phenotyp
recent
cohort
ci
patient
shown
higher
frequenc
cell
respons
elicit
overlap
librari
cterminu
peptid
healthi
ebv
carrier
unlik
studi
lcl
use
elicit
respons
frequenc
ebv
peptid
specif
cell
much
higher
cell
interestingli
specif
cell
ms
patient
control
also
react
myelin
peptid
viral
dnase
lytic
phase
protein
abl
reduc
surfac
express
mhc
class
also
similar
effect
mhc
class
ii
reduc
present
activ
cell
ebv
immediateearli
protein
act
inhibit
signal
caus
reduc
express
mhc
class
ii
molecul
downstream
interfer
nfb
complex
lysosom
proteas
system
typic
degrad
exogen
protein
present
mhc
class
ii
molecul
cell
surprisingli
intracellular
ebv
protein
express
b
cell
bypass
exogen
pathway
mhc
class
ii
pathway
research
ebvspecif
cell
respons
ms
patient
led
conflict
find
may
origin
result
fact
studi
employ
ebv
peptid
other
ebv
infect
b
cell
line
consensu
yet
whether
ebvspecif
cell
respons
decreas
increas
ms
patient
oppos
result
appear
stem
mainli
differ
experiment
set
summari
ebvspecif
cell
respons
promin
ebv
infect
lcl
use
increas
cell
respons
observ
experi
use
ebv
peptid
neuropatholog
studi
along
newer
sensit
molecular
techniqu
essenti
gener
confirm
refut
idea
infect
caus
ms
although
technic
practic
limit
sometim
led
confus
result
must
rememb
brain
sampl
limit
bias
toward
advanc
aggress
form
diseas
allow
longitudin
analys
nevertheless
histopatholog
remain
gold
standard
better
understand
pathophysiolog
diseas
earli
patholog
studi
electron
microscopi
found
tubular
paramyxoviruslik
intranuclear
inclus
activ
ms
lesion
later
describ
parainfluenza
viru
spheroid
particl
interpret
papovaviru
also
describ
type
inclus
soon
found
condit
thu
interpret
cell
organel
protein
artifact
develop
situ
hybridis
studi
pcr
allow
investig
virus
fail
demonstr
consist
presenc
measl
paramyxoviru
coronaviru
recent
variou
member
herpesviru
famili
consid
possibl
candid
involv
ms
pathogenesi
herp
simplex
viru
varicellazost
viru
epsteinbarr
viru
cytomegaloviru
human
found
brain
ms
patient
control
patient
use
pcr
southern
blot
hybridis
demonstr
differ
viral
infect
ms
brain
intrathec
synthesi
antibodi
direct
sever
virus
led
hypothesi
may
singl
specif
underli
viral
trigger
ms
sever
common
viral
infect
may
play
role
patholog
cascad
studi
antipathogen
respons
detail
may
aid
understand
hostviru
interact
cn
help
shed
light
immunopatholog
mechan
recent
stimul
sometim
controversi
patholog
studi
fuell
debat
role
ebv
ms
earli
studi
fail
show
consist
presenc
ebv
within
ms
brain
sander
et
al
found
ebv
ms
patient
control
activ
plaqu
inact
plaqu
use
pcr
hilton
et
al
find
ebv
cohort
ms
patient
includ
acut
chronic
activ
chronic
inact
shadow
plaqu
use
situ
hybridis
eber
ebv
encod
rna
suboptim
tissu
preserv
prevent
opsahl
kennedi
draw
conclus
presenc
ebv
ms
brain
recent
serafini
et
al
report
presenc
ebv
infect
b
cell
plasma
cell
brain
ms
case
present
inflammatori
neurolog
diseas
primari
cerebr
vascul
viral
enceph
mycot
mening
encephalopathi
unknown
origin
eight
ms
case
known
rich
b
cellplasma
cell
infiltr
ectop
b
cell
follicl
case
less
infiltr
situ
hybridis
eber
immunohistochem
techniqu
ebv
protein
use
b
cell
plasma
cell
posit
eber
highest
percentag
b
cell
ectop
follicl
note
case
promin
eber
cell
accumul
case
rich
b
cellsplasma
cell
infiltr
ectop
b
cell
follicl
less
infiltr
case
fewer
often
isol
eber
cell
viral
reactiv
demonstr
express
restrict
activ
lesion
ectop
follicl
cytotox
cell
key
player
elimin
viral
infect
cell
found
accumul
mainli
site
ebv
cell
three
consecut
studi
tri
unsuccess
reproduc
result
willi
et
al
examin
formalinfix
paraffinembed
tissu
specimen
ms
patient
select
specimen
b
cell
infiltr
use
wide
rang
techniqu
includ
situ
hybridis
eber
immunohistochemistri
quantit
realtim
pcr
detect
genom
ebv
rna
ms
lesion
addit
specimen
examin
b
cell
infiltr
aggreg
within
mening
b
cell
mening
infiltr
found
either
low
absent
case
b
cell
aggreg
within
brain
parenchyma
ebv
undetect
sampl
situ
hybridis
realtim
pcr
detect
lowlevel
ebv
infect
case
peferoen
et
al
made
similar
observ
undertook
studi
screen
specimen
ms
patient
includ
patient
die
age
addit
studi
block
use
serafini
studi
sixteen
patient
rich
b
cell
infiltr
although
folliclelik
structur
seen
specimen
eber
detect
one
tissu
specimen
situ
hybridis
also
show
lytic
cycl
marker
realtim
pcr
ebv
genom
encod
rna
neg
tissu
examin
recent
studi
screen
perivascular
area
ms
lesion
one
case
acut
dissemin
encephalomyel
adem
activ
lesion
overexpress
preselect
situ
hybridis
show
eber
cell
activ
ms
lesion
also
case
adem
final
recent
studi
use
nest
nonnest
realtim
pcr
detect
cell
specif
ebvspecif
transcript
freshfrozen
formalinfix
paraffinembed
ms
plaqu
singl
csf
blymphocyt
plasma
cell
reveal
evid
activ
ebv
infect
care
analysi
studi
underlin
difficulti
associ
neuropatholog
work
research
urgent
need
still
tri
optimis
molecular
techniqu
identifi
persist
viral
infect
brain
tissu
detect
often
hamper
postmortem
delay
tissu
fixat
work
consensu
lesion
stage
may
help
interpret
patholog
find
would
appear
ebv
cell
detect
ms
brain
mainli
within
activ
lesion
far
less
frequent
report
time
presenc
ebv
cell
may
specif
ms
brain
summari
ms
complex
diseas
huge
advanc
tool
use
studi
potenti
devast
neurolog
condit
mani
question
remain
role
ebv
ms
pathogenesi
remain
unknown
present
time
futur
studi
hope
help
us
understand
overal
clinic
impact
infect
affect
popul
sinc
ebv
yet
emerg
candid
interest
may
take
effort
see
whether
deserv
place
limelight
